Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroaki Fuji

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Scientific Reports|March 17, 2017
Actin-binding protein coronin 1A controls osteoclastic bone resorption by regulating lysosomal secretion of cathepsin KSaori Ohmae, Naruto Noma, Masayasu Toyomoto, et al.
International Cancer Conference Journal|July 4, 2024
A patient who underwent conversion surgery after atezolizumab plus bevacizumab for hepatocellular carcinoma with portal vein thrombosis and perihepatic lymph node metastases achieved a pathological complete responseMasayuki Okuno, Hideko Ohama, Ikuo Nakamura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2018
Serum Nardilysin, a Surrogate Marker for Epithelial-Mesenchymal Transition, Predicts Prognosis of Intrahepatic Cholangiocarcinoma after Surgical ResectionTomoaki Yoh, Etsuro Hatano, Yosuke Kasai, et al.
Asian Journal of Endoscopic Surgery|December 16, 2016
Prospective registry for laparoscopic liver resectionHiroaki Fuji, Etsuro Hatano, Satoru Seo, et al.
Cellular and Molecular Gastroenterology and Hepatology|April 12, 2026
Msln/Muc16 signaling in activated Portal Fibroblasts drives the development of cholestatic fibrosis and HCC in aged female Mdr2<sup>-/-</sup> miceSadatsugu Sakane, Takahiro Nishio, Hiroaki Fuji, et al.
Therapeutic Advances in Medical Oncology|September 18, 2023
Adverse events induced by durvalumab and tremelimumab combination regimens: a systematic review and meta-analysisHiromi Matsumoto, Kohei Somekawa, Nobuyuki Horita, et al.
Plos One|January 7, 2017
Chronological Profiling of Plasma Native Peptides after Hepatectomy in Pigs: Toward the Discovery of Human Biomarkers for Liver RegenerationKohta Iguchi, Etsuro Hatano, Takashi Nirasawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2021
Immunotherapy-based targeting of MSLN<sup>+</sup> activated portal fibroblasts is a strategy for treatment of cholestatic liver fibrosisTakahiro Nishio, Yukinori Koyama, Xiao Liu, et al.
European Clinical Respiratory Journal|July 30, 2024
Efficacy and safety of benralizumab in elderly patients with severe eosinophilic asthmaKohei Somekawa, Keisuke Watanabe, Kenichi Seki, et al.
Biochemical and Biophysical Research Communications|May 26, 2018
Necrostatin-7 suppresses RANK-NFATc1 signaling and attenuates macrophage to osteoclast differentiationHiroaki Fuji, Saori Ohmae, Naruto Noma, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Scientific Reports|March 17, 2017
Actin-binding protein coronin 1A controls osteoclastic bone resorption by regulating lysosomal secretion of cathepsin KSaori Ohmae, Naruto Noma, Masayasu Toyomoto, et al.
International Cancer Conference Journal|July 4, 2024
A patient who underwent conversion surgery after atezolizumab plus bevacizumab for hepatocellular carcinoma with portal vein thrombosis and perihepatic lymph node metastases achieved a pathological complete responseMasayuki Okuno, Hideko Ohama, Ikuo Nakamura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2018
Serum Nardilysin, a Surrogate Marker for Epithelial-Mesenchymal Transition, Predicts Prognosis of Intrahepatic Cholangiocarcinoma after Surgical ResectionTomoaki Yoh, Etsuro Hatano, Yosuke Kasai, et al.
Asian Journal of Endoscopic Surgery|December 16, 2016
Prospective registry for laparoscopic liver resectionHiroaki Fuji, Etsuro Hatano, Satoru Seo, et al.
Cellular and Molecular Gastroenterology and Hepatology|April 12, 2026
Msln/Muc16 signaling in activated Portal Fibroblasts drives the development of cholestatic fibrosis and HCC in aged female Mdr2<sup>-/-</sup> miceSadatsugu Sakane, Takahiro Nishio, Hiroaki Fuji, et al.
Therapeutic Advances in Medical Oncology|September 18, 2023
Adverse events induced by durvalumab and tremelimumab combination regimens: a systematic review and meta-analysisHiromi Matsumoto, Kohei Somekawa, Nobuyuki Horita, et al.
Plos One|January 7, 2017
Chronological Profiling of Plasma Native Peptides after Hepatectomy in Pigs: Toward the Discovery of Human Biomarkers for Liver RegenerationKohta Iguchi, Etsuro Hatano, Takashi Nirasawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2021
Immunotherapy-based targeting of MSLN<sup>+</sup> activated portal fibroblasts is a strategy for treatment of cholestatic liver fibrosisTakahiro Nishio, Yukinori Koyama, Xiao Liu, et al.
European Clinical Respiratory Journal|July 30, 2024
Efficacy and safety of benralizumab in elderly patients with severe eosinophilic asthmaKohei Somekawa, Keisuke Watanabe, Kenichi Seki, et al.
Biochemical and Biophysical Research Communications|May 26, 2018
Necrostatin-7 suppresses RANK-NFATc1 signaling and attenuates macrophage to osteoclast differentiationHiroaki Fuji, Saori Ohmae, Naruto Noma, et al.
Pageof 4